Concepedia

Hiddo J.L. Heerspink

HJ

363

Publications

39.5K

Citations

94

H-Index

2007

Active since

Affiliations

University Medical Center Groningen(Current)

University of Groningen

The George Institute for Global Health

University of Copenhagen

UNSW Sydney

Hiddo J.L. Heerspink is an author at University Medical Center Groningen specializing in chronic kidney disease, medicine, and nephrology.

ORCID

Top concepts

Publications per year

2007–2025

363

Publications

363

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 5.7K citations · Full text

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter et al. · New England Journal of Medicine · 2020 · 4.8K citations · Full text

Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

Dick de Zeeuw, Tadao Akizawa, Paul Audhya et al. · New England Journal of Medicine · 2013 · 969 citations · Full text

Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes

Hiddo J.L. Heerspink, Dick de Zeeuw, Li Wie et al. · Diabetes Obesity and Metabolism · 2013 · 801 citations · Full text

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn et al. · The Lancet Diabetes & Endocrinology · 2019 · 656 citations · Full text

, , +10

Rows per page

1–5 of 363